• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET/CT 总病灶糖酵解是软组织肉瘤预后的可靠预测指标。

Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma.

机构信息

Department of Orthopaedic Surgery, Seoul National University Hospital, 101 Daehak-ro Jongno-gu, Seoul, 110-744, Korea.

出版信息

Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1836-42. doi: 10.1007/s00259-013-2511-y. Epub 2013 Jul 24.

DOI:10.1007/s00259-013-2511-y
PMID:23880967
Abstract

PURPOSE

Preoperative identification of aggressiveness is important for the establishment of a treatment strategy in patients with soft-tissue sarcoma (STS). We compared the predictive values of various metabolic parameters derived from PET/CT with (18)F-FDG, including maximal standardized uptake value (SUVmax), total lesion glycolysis (TLG) and metabolic tumour volume (MTV).

METHODS

A total of 66 patients with STS who had undergone FDG PET/CT before tumour resection were reviewed retrospectively. We determined SUVmax, TLG and MTV to compare their value in predicting disease progression, which was defined as local recurrence and metastases. Receiver operating characteristic curve (ROC) analysis was used to compare the accuracy. Univariate and multivariate analyses of conventional clinicopathological variables were used to compare the reliability of the metabolic parameters.

RESULTS

TLG exhibited greater accuracy than SUVmax or MTV in ROC analysis (area under curve, AUC, 0.802, 0.726 and 0.681, respectively). The cut-off values for disease progression derived from the AUC data were TLG 250; SUVmax 6.0, and MTV 40 cm(3). In univariate analysis, TLG (>250) was a more significant predictive factor than SUVmax and MTV (P < 0.001, P = 0.031 and P = 0.022, respectively). TLG was the only meaningful metabolic parameter in the multivariate analysis (P = 0.008) other than presence of metastasis at diagnosis (P = 0.003).

CONCLUSION

TLG is a more accurate predictor of disease progression than SUVmax or MTV. TLG enables accurate preoperative assessment of aggressiveness comparable with conventional clinicopathological parameters.

摘要

目的

术前识别侵袭性对于软组织肉瘤(STS)患者治疗策略的制定非常重要。我们比较了来自 FDG PET/CT 的各种代谢参数(包括最大标准化摄取值[SUVmax]、总病灶糖酵解[TLG]和代谢肿瘤体积[MTV])的预测值。

方法

回顾性分析了 66 例在肿瘤切除前接受 FDG PET/CT 的 STS 患者。我们测定了 SUVmax、TLG 和 MTV,以比较它们在预测疾病进展(定义为局部复发和转移)方面的价值。使用受试者工作特征曲线(ROC)分析比较准确性。使用单变量和多变量分析比较常规临床病理变量的可靠性。

结果

在 ROC 分析中,TLG 的准确性大于 SUVmax 或 MTV(曲线下面积[AUC],分别为 0.802、0.726 和 0.681)。从 AUC 数据得出的疾病进展的截断值为 TLG 250;SUVmax 为 6.0,MTV 为 40 cm3。在单变量分析中,TLG(>250)比 SUVmax 和 MTV 更具有预测价值(P < 0.001、P = 0.031 和 P = 0.022)。除了初诊时存在转移(P = 0.003)外,TLG 是多变量分析中唯一有意义的代谢参数(P = 0.008)。

结论

TLG 是疾病进展的预测指标,比 SUVmax 或 MTV 更准确。TLG 能够准确地对术前侵袭性进行评估,与常规临床病理参数相当。

相似文献

1
Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma.18F-FDG PET/CT 总病灶糖酵解是软组织肉瘤预后的可靠预测指标。
Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1836-42. doi: 10.1007/s00259-013-2511-y. Epub 2013 Jul 24.
2
Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.预处理 18F-FDG PET/CT 测量的容积参数对皮肤恶性黑色素瘤患者的预后价值。
Clin Nucl Med. 2016 Jun;41(6):e266-73. doi: 10.1097/RLU.0000000000001205.
3
Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.基于体素的FDG PET参数可能预测软组织肉瘤的增殖潜能。
Ann Nucl Med. 2019 Jan;33(1):22-31. doi: 10.1007/s12149-018-1298-0. Epub 2018 Sep 8.
4
Differentiation of soft tissue and bone sarcomas from benign lesions utilizing F-FDG PET/CT-derived parameters.利用 F-FDG PET/CT 衍生参数区分软组织和骨肉瘤与良性病变。
BMC Med Imaging. 2020 Jul 25;20(1):85. doi: 10.1186/s12880-020-00486-z.
5
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.术前 ¹⁸F-FDG PET/CT 代谢肿瘤体积和总病变糖酵解对胰腺癌患者的预后价值。
J Nucl Med. 2014 Jun;55(6):898-904. doi: 10.2967/jnumed.113.131847. Epub 2014 Apr 7.
6
Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity.(18)F-FDG PET/CT 测量的术前代谢肿瘤体积和总病变糖酵解对口腔鳞状细胞癌的预后意义。
Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):452-61. doi: 10.1007/s00259-013-2571-z. Epub 2013 Oct 1.
7
Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.使用术前18F-FDG PET/CT测量的代谢肿瘤体积和总病灶糖酵解可预测子宫内膜癌的复发。
BJOG. 2014 Aug;121(9):1097-106; discussion 1106. doi: 10.1111/1471-0528.12543. Epub 2014 Jan 8.
8
The correlation of F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer.乳腺癌中 F-FDG PET/CT 代谢参数与临床病理因素及预后的相关性。
Clin Transl Oncol. 2021 Mar;23(3):620-627. doi: 10.1007/s12094-020-02457-w. Epub 2020 Jul 18.
9
[Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].[预处理(18)F-FDG PET-CT对晚期弥漫性大B细胞淋巴瘤患者的预后价值]
Zhonghua Zhong Liu Za Zhi. 2018 Jul 23;40(7):528-533. doi: 10.3760/cma.j.issn.0253-3766.2018.07.009.
10
Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.标准化摄取值和代谢肿瘤体积在¹⁸F-FDG PET/CT上对口咽鳞状细胞癌的预后意义
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1353-61. doi: 10.1007/s00259-015-3051-4. Epub 2015 Jun 12.

引用本文的文献

1
Prognostic significance of F-FDG PET/CT parameters in soft tissue sarcoma: a systematic review and meta-analysis.F-FDG PET/CT参数在软组织肉瘤中的预后意义:一项系统评价和荟萃分析
Cancer Imaging. 2025 Jul 29;25(1):94. doi: 10.1186/s40644-025-00912-x.
2
The role of positron emission tomography in the evaluation and management of musculoskeletal lesions-a narrative review.正电子发射断层扫描在肌肉骨骼病变评估与管理中的作用——一篇叙述性综述
Ann Jt. 2025 Jan 21;10:8. doi: 10.21037/aoj-24-26. eCollection 2025.
3
Predictive Value of Quantitative Parameters of F-FDG PET/CT in Patients with Liposarcoma.

本文引用的文献

1
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.(18)F-FDG PET 代谢肿瘤负荷对非小细胞肺癌手术患者的预后价值。
Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.
2
The diagnostic and prognostic value of ¹⁸F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients.¹⁸F-FDG PET/CT 在高级骨和软组织肉瘤初始评估中的诊断和预后价值。89 例患者的回顾性研究。
Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1416-24. doi: 10.1007/s00259-012-2159-z. Epub 2012 Jun 15.
3
F-FDG PET/CT定量参数在脂肪肉瘤患者中的预测价值
Diagnostics (Basel). 2024 Sep 12;14(18):2021. doi: 10.3390/diagnostics14182021.
4
Are MTV and TLG Accurate for Quantifying the Intensity of Brown Adipose Tissue Activation?MTV和TLG在量化棕色脂肪组织激活强度方面准确吗?
Biomedicines. 2024 Jan 11;12(1):151. doi: 10.3390/biomedicines12010151.
5
Volume-based F-FDG PET/CT predicts prognosis and outcome of active surveillance for intra-abdominal desmoid tumor.基于体素的 F-FDG PET/CT 预测腹腔内韧带样纤维瘤主动监测的预后和结局。
Abdom Radiol (NY). 2024 Mar;49(3):958-963. doi: 10.1007/s00261-023-04145-z. Epub 2024 Jan 21.
6
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study.通过18F-FDG-PET/CT解读软组织肉瘤的代谢活性与免疫格局之间的相关性:来自NEOSARCOMICS研究的见解
Biomark Res. 2024 Jan 7;12(1):3. doi: 10.1186/s40364-023-00552-y.
7
Preoperative assessment of retroperitoneal Liposarcoma using volume-based F-FDG PET/CT: implications for surgical strategy and prognosis.使用基于体素的 F-FDG PET/CT 对腹膜后脂肪肉瘤进行术前评估:对手术策略和预后的影响。
BMC Med Imaging. 2023 Dec 18;23(1):215. doi: 10.1186/s12880-023-01179-z.
8
Risk stratification of oesophageal squamous cell carcinoma using change in total lesion glycolysis and number of PET-positive lymph nodes.使用总病变糖酵解变化和 PET 阳性淋巴结数量对食管鳞状细胞癌进行风险分层。
Br J Cancer. 2023 May;128(10):1879-1887. doi: 10.1038/s41416-023-02151-y. Epub 2023 Feb 25.
9
The reproducibility of MTV and TLG of soft tissue tumors calculated by FDG-PET: Comparison between the lower limit by the fixed value SUV 2.5 and that value by 30% of SUVmax.软组织肿瘤 FDG-PET 摄取值 MTV 和 TLG 的可重复性:固定 SUV 2.5 下限值与 SUVmax 30%值的比较。
Jpn J Radiol. 2023 May;41(5):531-540. doi: 10.1007/s11604-022-01378-8. Epub 2023 Jan 13.
10
The reduction of F-FDG uptake ability of tumor tissue after neoadjuvant chemoradiotherapy in locally advanced rectal cancer can effectively reflect the degree of tumor regression.局部晚期直肠癌新辅助放化疗后肿瘤组织F-FDG摄取能力的降低可有效反映肿瘤退缩程度。
Front Oncol. 2022 Dec 22;12:1037783. doi: 10.3389/fonc.2022.1037783. eCollection 2022.
Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
治疗前 FDG PET/CT 全身总病变糖酵解对非小细胞肺癌的预后价值。
Radiology. 2012 Aug;264(2):559-66. doi: 10.1148/radiol.12111148. Epub 2012 Jun 12.
4
Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients.18F-FDG PET/CT 代谢活性与骨和软组织肉瘤组织病理学特征的相关性:136 例患者的回顾性研究。
AJR Am J Roentgenol. 2012 Jun;198(6):1409-16. doi: 10.2214/AJR.11.7560.
5
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
6
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.术前代谢肿瘤体积和总病变糖酵解对上皮性卵巢癌患者的预后价值。
Ann Surg Oncol. 2012 Jun;19(6):1966-72. doi: 10.1245/s10434-011-2153-x. Epub 2011 Nov 29.
7
Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma.使用代谢和容积 18F-FDG PET/CT 指标预测骨肉瘤儿童和青年患者在一个疗程后和新辅助化疗结束时的肿瘤坏死分数。
Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):39-49. doi: 10.1007/s00259-011-1936-4. Epub 2011 Sep 28.
8
Utilization of positron emission tomography in the management of patients with sarcoma.正电子发射断层扫描在肉瘤患者管理中的应用。
Curr Opin Oncol. 2009 Jul;21(4):345-51. doi: 10.1097/CCO.0b013e32832c95e2.
9
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.代谢肿瘤体积可预测头颈癌的复发和死亡。
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1335-41. doi: 10.1016/j.ijrobp.2008.10.060. Epub 2009 Mar 14.
10
Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome.肉瘤中18F-FDG摄取的空间异质性作为患者预后的预测指标。
J Nucl Med. 2008 Dec;49(12):1973-9. doi: 10.2967/jnumed.108.053397. Epub 2008 Nov 7.